Paul Joseph Barreira, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soccer | 4 | 2019 | 131 | 1.160 |
Why?
|
Employment, Supported | 6 | 2011 | 28 | 0.980 |
Why?
|
Rehabilitation, Vocational | 3 | 2011 | 82 | 0.620 |
Why?
|
Community Mental Health Services | 5 | 2010 | 385 | 0.510 |
Why?
|
Mental Disorders | 15 | 2012 | 6570 | 0.510 |
Why?
|
Leg Injuries | 1 | 2016 | 178 | 0.480 |
Why?
|
Athletic Injuries | 3 | 2019 | 1151 | 0.410 |
Why?
|
Rehabilitation | 1 | 2010 | 134 | 0.340 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 483 | 0.330 |
Why?
|
Mental Health Services | 6 | 2008 | 1641 | 0.320 |
Why?
|
Ticlopidine | 1 | 2014 | 899 | 0.310 |
Why?
|
Personal Autonomy | 1 | 2008 | 300 | 0.260 |
Why?
|
Drug Hypersensitivity | 1 | 2014 | 889 | 0.250 |
Why?
|
Patient Participation | 3 | 2010 | 1441 | 0.240 |
Why?
|
Muscle, Skeletal | 2 | 2016 | 4920 | 0.230 |
Why?
|
Community Mental Health Centers | 2 | 2001 | 102 | 0.220 |
Why?
|
Choice Behavior | 2 | 2008 | 801 | 0.220 |
Why?
|
Social Support | 1 | 2011 | 2112 | 0.190 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3066 | 0.190 |
Why?
|
Mumps virus | 1 | 2020 | 24 | 0.180 |
Why?
|
Mumps | 1 | 2020 | 65 | 0.170 |
Why?
|
Contract Services | 1 | 1999 | 94 | 0.170 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3606 | 0.160 |
Why?
|
Certification | 3 | 2006 | 424 | 0.160 |
Why?
|
Schizophrenic Psychology | 2 | 2006 | 1677 | 0.160 |
Why?
|
Jogging | 1 | 2016 | 18 | 0.150 |
Why?
|
Program Evaluation | 2 | 2010 | 2484 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2010 | 9812 | 0.140 |
Why?
|
Self-Injurious Behavior | 2 | 2012 | 461 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 668 | 0.140 |
Why?
|
Acceleration | 1 | 2016 | 181 | 0.130 |
Why?
|
Muscle Strength | 1 | 2019 | 582 | 0.130 |
Why?
|
Peer Group | 2 | 2011 | 635 | 0.120 |
Why?
|
Geographic Information Systems | 1 | 2016 | 281 | 0.120 |
Why?
|
Propranolol | 3 | 1984 | 499 | 0.120 |
Why?
|
Professional-Patient Relations | 2 | 2010 | 736 | 0.120 |
Why?
|
Motor Skills | 1 | 2016 | 520 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2001 | 7274 | 0.110 |
Why?
|
Immobilization | 1 | 2014 | 236 | 0.110 |
Why?
|
Life Expectancy | 1 | 1999 | 1208 | 0.110 |
Why?
|
Motivation | 2 | 2005 | 1965 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 780 | 0.100 |
Why?
|
Students | 2 | 2012 | 1637 | 0.100 |
Why?
|
Anthropometry | 1 | 2016 | 1344 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2000 | 941 | 0.100 |
Why?
|
Massachusetts | 6 | 2008 | 8669 | 0.100 |
Why?
|
Insurance, Psychiatric | 1 | 2010 | 69 | 0.090 |
Why?
|
Muscular Atrophy | 1 | 2014 | 346 | 0.090 |
Why?
|
Psychotic Disorders | 4 | 2004 | 3028 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1779 | 0.090 |
Why?
|
Alcoholic Intoxication | 1 | 2011 | 188 | 0.090 |
Why?
|
Adult | 25 | 2019 | 213394 | 0.090 |
Why?
|
Health Services Research | 2 | 2009 | 1832 | 0.090 |
Why?
|
Schizophrenia | 4 | 2006 | 6866 | 0.080 |
Why?
|
Muscle Proteins | 1 | 2014 | 1158 | 0.080 |
Why?
|
Akathisia, Drug-Induced | 3 | 1984 | 67 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2004 | 4239 | 0.080 |
Why?
|
Health Benefit Plans, Employee | 1 | 2010 | 332 | 0.080 |
Why?
|
Male | 27 | 2019 | 349022 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1480 | 0.080 |
Why?
|
Psychomotor Agitation | 3 | 1984 | 287 | 0.080 |
Why?
|
Psychiatry | 1 | 1999 | 1686 | 0.070 |
Why?
|
Medicaid | 2 | 2004 | 2711 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 1992 | 891 | 0.070 |
Why?
|
Health Policy | 1 | 1999 | 2655 | 0.070 |
Why?
|
Humans | 43 | 2020 | 739398 | 0.070 |
Why?
|
Emotions | 1 | 2018 | 2642 | 0.070 |
Why?
|
Models, Organizational | 2 | 2000 | 573 | 0.070 |
Why?
|
Universities | 1 | 2011 | 946 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 2 | 2010 | 3021 | 0.060 |
Why?
|
Self-Help Groups | 1 | 2006 | 188 | 0.060 |
Why?
|
Quality Assurance, Health Care | 3 | 2001 | 2213 | 0.060 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1994 | 1442 | 0.060 |
Why?
|
Random Allocation | 1 | 2009 | 2417 | 0.060 |
Why?
|
Vertigo | 1 | 2006 | 200 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2397 | 0.060 |
Why?
|
Thirst | 1 | 1984 | 38 | 0.060 |
Why?
|
Antidepressive Agents | 2 | 1988 | 2836 | 0.060 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1984 | 61 | 0.060 |
Why?
|
Employment | 1 | 2010 | 1119 | 0.060 |
Why?
|
Paranoid Disorders | 1 | 1983 | 59 | 0.060 |
Why?
|
Metoprolol | 1 | 1984 | 92 | 0.060 |
Why?
|
Drinking Behavior | 1 | 1984 | 103 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2012 | 1236 | 0.060 |
Why?
|
Hospitals, Psychiatric | 2 | 2001 | 332 | 0.060 |
Why?
|
Research Subjects | 1 | 2005 | 237 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2007 | 725 | 0.050 |
Why?
|
New York City | 2 | 2007 | 704 | 0.050 |
Why?
|
Paroxetine | 1 | 2003 | 182 | 0.050 |
Why?
|
Suicide | 1 | 2012 | 1469 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5591 | 0.050 |
Why?
|
Program Development | 1 | 2008 | 1313 | 0.050 |
Why?
|
Needs Assessment | 1 | 2008 | 1145 | 0.050 |
Why?
|
Assertiveness | 1 | 2001 | 18 | 0.050 |
Why?
|
Group Homes | 1 | 2001 | 34 | 0.050 |
Why?
|
Commitment of Mentally Ill | 1 | 2001 | 93 | 0.050 |
Why?
|
Data Collection | 1 | 2010 | 3341 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4022 | 0.050 |
Why?
|
Bereavement | 1 | 2004 | 273 | 0.050 |
Why?
|
Antipsychotic Agents | 4 | 1992 | 3055 | 0.040 |
Why?
|
Benchmarking | 2 | 2010 | 1034 | 0.040 |
Why?
|
Muscle Strength Dynamometer | 1 | 2019 | 43 | 0.040 |
Why?
|
Dementia | 1 | 1994 | 2488 | 0.040 |
Why?
|
Female | 23 | 2018 | 378853 | 0.040 |
Why?
|
Fluoxetine | 1 | 2003 | 749 | 0.040 |
Why?
|
Memory Disorders | 1 | 2006 | 1183 | 0.040 |
Why?
|
Proprioception | 1 | 2019 | 132 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19811 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 469 | 0.040 |
Why?
|
Models, Neurological | 1 | 2006 | 1769 | 0.040 |
Why?
|
Bipolar Disorder | 5 | 1999 | 5023 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2007 | 1503 | 0.040 |
Why?
|
Public Health Administration | 1 | 1999 | 241 | 0.040 |
Why?
|
Sampling Studies | 1 | 2018 | 624 | 0.040 |
Why?
|
Placebos | 1 | 2001 | 1678 | 0.030 |
Why?
|
United States | 9 | 2020 | 69573 | 0.030 |
Why?
|
Depressive Disorder | 2 | 1988 | 3743 | 0.030 |
Why?
|
Quality Improvement | 1 | 2011 | 3730 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2001 | 793 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2001 | 865 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15036 | 0.030 |
Why?
|
Body Fluid Compartments | 1 | 2014 | 52 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 35326 | 0.030 |
Why?
|
Life Change Events | 2 | 2012 | 936 | 0.030 |
Why?
|
Middle Aged | 12 | 2011 | 212863 | 0.030 |
Why?
|
Depressive Disorder, Major | 2 | 2003 | 4606 | 0.030 |
Why?
|
Teaching | 1 | 2001 | 1166 | 0.030 |
Why?
|
Patient Care Team | 2 | 2001 | 2527 | 0.030 |
Why?
|
Aged | 6 | 2014 | 162698 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2789 | 0.030 |
Why?
|
Viral Proteins | 1 | 2020 | 1900 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2003 | 2138 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1992 | 380 | 0.030 |
Why?
|
Habituation, Psychophysiologic | 1 | 2012 | 155 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2005 | 3514 | 0.030 |
Why?
|
Hypertrophy | 1 | 2014 | 565 | 0.030 |
Why?
|
Biological Availability | 1 | 1992 | 390 | 0.030 |
Why?
|
Solutions | 1 | 1992 | 426 | 0.030 |
Why?
|
Resistance Training | 1 | 2014 | 164 | 0.030 |
Why?
|
Health Care Surveys | 1 | 1999 | 2448 | 0.030 |
Why?
|
Length of Stay | 2 | 2001 | 6295 | 0.020 |
Why?
|
Knee Joint | 1 | 2019 | 1676 | 0.020 |
Why?
|
Homosexuality | 1 | 2011 | 265 | 0.020 |
Why?
|
Social Adjustment | 1 | 2012 | 632 | 0.020 |
Why?
|
Adolescent | 7 | 2019 | 85405 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5721 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2006 | 15511 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 56255 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9133 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 38942 | 0.020 |
Why?
|
Atrophy | 1 | 1994 | 1571 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1994 | 1850 | 0.020 |
Why?
|
Insurance, Health | 1 | 2001 | 2491 | 0.020 |
Why?
|
Cause of Death | 1 | 1999 | 3564 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2014 | 904 | 0.020 |
Why?
|
Dietary Proteins | 1 | 2014 | 959 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4791 | 0.020 |
Why?
|
Anger | 1 | 2011 | 401 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2012 | 746 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 3232 | 0.020 |
Why?
|
Parkinson Disease, Secondary | 2 | 1984 | 126 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2009 | 419 | 0.020 |
Why?
|
Lithiasis | 1 | 2006 | 20 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2007 | 299 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 24714 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2011 | 76631 | 0.020 |
Why?
|
Pilot Projects | 1 | 1999 | 8275 | 0.020 |
Why?
|
Haloperidol | 2 | 1984 | 397 | 0.020 |
Why?
|
Researcher-Subject Relations | 1 | 2005 | 16 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12951 | 0.020 |
Why?
|
Administration, Oral | 1 | 1992 | 3909 | 0.020 |
Why?
|
Amantadine | 1 | 1984 | 55 | 0.020 |
Why?
|
Thioridazine | 1 | 1984 | 33 | 0.020 |
Why?
|
Perphenazine | 1 | 1984 | 34 | 0.020 |
Why?
|
Doxepin | 1 | 1983 | 16 | 0.010 |
Why?
|
Phenelzine | 1 | 1983 | 28 | 0.010 |
Why?
|
Imipramine | 1 | 1983 | 97 | 0.010 |
Why?
|
Vestibular Diseases | 1 | 2006 | 218 | 0.010 |
Why?
|
Amitriptyline | 1 | 1983 | 108 | 0.010 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1983 | 164 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4660 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1984 | 345 | 0.010 |
Why?
|
Salaries and Fringe Benefits | 1 | 2005 | 264 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1409 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 1992 | 2275 | 0.010 |
Why?
|
Mothers | 1 | 2012 | 2143 | 0.010 |
Why?
|
Hospitals, State | 1 | 2001 | 29 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3280 | 0.010 |
Why?
|
Hospitalization | 1 | 2001 | 10208 | 0.010 |
Why?
|
Licensure, Hospital | 1 | 2001 | 3 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 2003 | 394 | 0.010 |
Why?
|
Hospitals, Private | 1 | 2001 | 62 | 0.010 |
Why?
|
Delusions | 1 | 1983 | 300 | 0.010 |
Why?
|
Attitude to Death | 1 | 2004 | 381 | 0.010 |
Why?
|
Hyponatremia | 1 | 1984 | 296 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2006 | 834 | 0.010 |
Why?
|
Restless Legs Syndrome | 1 | 1983 | 228 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9684 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2007 | 2533 | 0.010 |
Why?
|
Hospitals, Public | 1 | 2001 | 204 | 0.010 |
Why?
|
Insurance Claim Review | 1 | 2004 | 720 | 0.010 |
Why?
|
Respiratory Sounds | 1 | 1984 | 692 | 0.010 |
Why?
|
Risk Factors | 2 | 2012 | 71974 | 0.010 |
Why?
|
Functional Laterality | 1 | 2006 | 2291 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2004 | 1675 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2006 | 1671 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1984 | 1238 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2006 | 1899 | 0.010 |
Why?
|
Sex Factors | 1 | 2011 | 10398 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13880 | 0.010 |
Why?
|
Dexamethasone | 1 | 1983 | 1948 | 0.010 |
Why?
|
Demography | 1 | 2001 | 1650 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13402 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29658 | 0.010 |
Why?
|
Neurons | 1 | 1994 | 9336 | 0.010 |
Why?
|
Oxygen | 1 | 2006 | 4158 | 0.010 |
Why?
|
Hippocampus | 1 | 2006 | 3657 | 0.010 |
Why?
|
Time Factors | 2 | 2006 | 40050 | 0.010 |
Why?
|
History, 20th Century | 1 | 2001 | 2742 | 0.010 |
Why?
|
Acute Disease | 1 | 1984 | 7128 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 6963 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2005 | 3382 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1988 | 7897 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 1983 | 2674 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10247 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2006 | 4026 | 0.010 |
Why?
|
Health Status | 1 | 2004 | 4013 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1994 | 20055 | 0.010 |
Why?
|
Brain Mapping | 1 | 2006 | 6666 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2005 | 12328 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10362 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3029 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2001 | 1891 | 0.010 |
Why?
|
Research Design | 1 | 2005 | 5959 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 11985 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8605 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2006 | 21694 | 0.000 |
Why?
|
Blood Pressure | 1 | 1984 | 8554 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1983 | 12948 | 0.000 |
Why?
|
Brain | 1 | 1994 | 26345 | 0.000 |
Why?
|
Medicare | 1 | 2001 | 6497 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1984 | 376 | 0.000 |
Why?
|
Lithium | 1 | 1984 | 603 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1983 | 1809 | 0.000 |
Why?
|